Pralhad Sadashiv Patki
Pralhad Sadashiv Patki has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
J Malini
Department of Microbiology, K.L.E. College of Dental Sciences and Hospital, Bangalore, India
1 shared publicationM.G. Shekar Kumaran
Shree Sai Hospitals, Choolaimedu, Chennai, India
1 shared publication- Mohamed Rafiq
Department of Pharmacology, R&D Center, The Himalaya Drug Company, Bangalore, India
1 shared publication Mohd. Azeemuddin Mukram
Department of Pharmacology, R&D Center, The Himalaya Drug Company, Makali, Bangalore, India
1 shared publicationPrakash S Tandur
Department of Oral and Maxillofacial Surgery, K.L.E. College of Dental Sciences and Hospital, Bangalore, India
1 shared publicationRk Sharma
Department of Dravyaguna and Rasashastra, Government Ayurvedic College, Guwahati, Assam, India
1 shared publication
Latest Publications
- Open Access
- 25 March 2013
- Published by University Library System, University of Pittsburgh in Central Asian Journal of Global Health
- Vol. 2 (1) , 14
Speman®, A Proprietary Ayurvedic Formulation, Reverses Cyclophosphamide-Induced Oligospermia In Rats.
Background: This investigation was aimed to evaluate the effect of Speman®, a well known ayurvedic proprietary preparation, in an experimental model of cyclophosphamide-(CP) induced oligospermia in rats.Materials and Methods: Thirty male rats were randomized in to five, equally-sized groups. Rats in group 1 served as a normal control; group 2 served as an untreated positive control; groups 3, 4, 5 received Speman® granules at doses of 300, 600, and 900mg/kg body weight p.o. respectively, once daily for 13 days. On day four, one hour after the respective treatment, oligospermia was induced by administering a single dose of CP (100mg/kg body weight p.o.) to all the groups except group1. At the end of the study period the rats were euthanised and accessory reproductive organs were weighed and subjected to histopathological examination. The semen samples were subject to enumeration of sperms. Weight of the reproductive organs, histopathological examination of the tissues, and sperm count were the parameters studied to understand the effect of Speman® on rats with CP-induced oligospermia.Results: Changes that occurred due to the administration of CP at a dose of 100 mg/kg body weight were dose dependently reversed with Speman® at a dose of 300, 600, and 900 mg/kg body weight. There was a statistically significant increase in sperm count and the weight of the seminal vesicle, epididymis, and prostate.Conclusion: Findings of this investigation indicate that Speman® dose dependently reversed the CP-induced derangement of various parameters pertaining to the reproductive system. This could explain the total beneficial actions of Speman® reported in several other clinical trials.
- 25 March 2013
- Published by University Library System, University of Pittsburgh in Central Asian Journal of Global Health
- Vol. 2 (1) , 14
Open AccessSpeman®, A Proprietary Ayurvedic Formulation, Reverses Cyclophosphamide-Induced Oligospermia In Rats.
Background: This investigation was aimed to evaluate the effect of Speman®, a well known ayurvedic proprietary preparation, in an experimental model of cyclophosphamide-(CP) induced oligospermia in rats.Materials and Methods: Thirty male rats were randomized in to five, equally-sized groups. Rats in group 1 served as a normal control; group 2 served as an untreated positive control; groups 3, 4, 5 received Speman® granules at doses of 300, 600, and 900mg/kg body weight p.o. respectively, once daily for 13 days. On day four, one hour after the respective treatment, oligospermia was induced by administering a single dose of CP (100mg/kg body weight p.o.) to all the groups except group1. At the end of the study period the rats were euthanised and accessory reproductive organs were weighed and subjected to histopathological examination. The semen samples were subject to enumeration of sperms. Weight of the reproductive organs, histopathological examination of the tissues, and sperm count were the parameters studied to understand the effect of Speman® on rats with CP-induced oligospermia.Results: Changes that occurred due to the administration of CP at a dose of 100 mg/kg body weight were dose dependently reversed with Speman® at a dose of 300, 600, and 900 mg/kg body weight. There was a statistically significant increase in sperm count and the weight of the seminal vesicle, epididymis, and prostate.Conclusion: Findings of this investigation indicate that Speman® dose dependently reversed the CP-induced derangement of various parameters pertaining to the reproductive system. This could explain the total beneficial actions of Speman® reported in several other clinical trials.
- 30 April 2011
- Published by Elsevier in European Journal of Integrative Medicine
- Vol. 3 (1) , 23-28
Evaluation of an Ayurvedic formulation (Cystone), in urolithiasis: A double blind, placebo-controlled study
- 30 April 2011
- Published by Elsevier in European Journal of Integrative Medicine
- Vol. 3 (1) , 23-28
Evaluation of an Ayurvedic formulation (Cystone), in urolithiasis: A double blind, placebo-controlled study
- 27 February 2011
- Published by Springer Nature in Urological Research
- Vol. 39 (4) , 323
Cystone in cystine stone formers
- 27 February 2011
- Published by Springer Nature in Urological Research
- Vol. 39 (4) , 323
Cystone in cystine stone formers
- Open Access
- 1 July 2010
- Published by Taylor & Francis in Journal of Experimental Pharmacology
- Vol. 2, 105-109
Clinical evaluation of a novel herbal dental cream in plaque formation: a double-blind, randomized, controlled clinical trial
Background: The aim of this study was to evaluate the efficacy and safety of herbal dental cream in comparison to fluoride dental cream. Objectives: Clinical evaluation of a novel herbal dental cream in plaque formation: a double-blind, randomized, controlled clinical trial. Methods: One hundred and two patients with established dental plaque were randomly assigned to either herbal dental group or fluoride dental group for six weeks in a double-blind design. Improvement in plaque index, oral hygiene status, bleeding index, and gingival index was evaluated in these patients along with microbiological study. Results: Results indicated a significant reduction in plaque index, gingival index, oral hygiene index, and microbial growth in both groups. Difference between the groups was not significant. There was no significant change in bleeding index. No adverse events were reported and both the dental creams were well tolerated. Conclusion: The finding of this preliminary study indicates that herbal dental cream is as safe and effective as fluoride dental cream, but not superior to it.
- 1 July 2010
- Published by Taylor & Francis in Journal of Experimental Pharmacology
- Vol. 2, 105-109
Open AccessClinical evaluation of a novel herbal dental cream in plaque formation: a double-blind, randomized, controlled clinical trial
Background: The aim of this study was to evaluate the efficacy and safety of herbal dental cream in comparison to fluoride dental cream. Objectives: Clinical evaluation of a novel herbal dental cream in plaque formation: a double-blind, randomized, controlled clinical trial. Methods: One hundred and two patients with established dental plaque were randomly assigned to either herbal dental group or fluoride dental group for six weeks in a double-blind design. Improvement in plaque index, oral hygiene status, bleeding index, and gingival index was evaluated in these patients along with microbiological study. Results: Results indicated a significant reduction in plaque index, gingival index, oral hygiene index, and microbial growth in both groups. Difference between the groups was not significant. There was no significant change in bleeding index. No adverse events were reported and both the dental creams were well tolerated. Conclusion: The finding of this preliminary study indicates that herbal dental cream is as safe and effective as fluoride dental cream, but not superior to it.
- Open Access
- 1 January 2010
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 1 (1) , 45-51
Double-blind, placebo-controlled clinical evaluation of an Ayurvedic formulation (GlucoCare capsules) in non-insulin dependent diabetes mellitus
- 1 January 2010
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 1 (1) , 45-51
Open AccessDouble-blind, placebo-controlled clinical evaluation of an Ayurvedic formulation (GlucoCare capsules) in non-insulin dependent diabetes mellitus